Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared to Placebo on Synovial Fluid Biomarkers in Participants with Knee Osteoarthritis Pain

Next Previous
Trial Profile

A Phase 2, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared to Placebo on Synovial Fluid Biomarkers in Participants with Knee Osteoarthritis Pain

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 11 Apr 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pentosan polysulfate (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Sponsors Paradigm Biopharma

    • Most Recent Events

    • 04 Apr 2024 Planned End Date changed from 6 Dec 2024 to 6 Jan 2025.
    • 04 Apr 2024 Status changed from recruiting to active, no longer recruiting.
    • 04 May 2022 According to a Paradigm Biopharma media release, study is currently screening and enrolling subjects in eight sites across Australia and 21 of the 56 selected sites in the U.S.Site activations in the U.S. will continue, and UK and EU sites are also being initiated throughout CY22.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top